1 Recombinant Follicle Stimulating Hormone Market Overview 1.1 Recombinant Follicle Stimulating Hormone Product Overview 1.2 Recombinant Follicle Stimulating Hormone Market Segment by Type 1.2.1 75IU 1.2.2 150IU 1.2.3 Others 1.3 Global Recombinant Follicle Stimulating Hormone Market Size by Type 1.3.1 Global Recombinant Follicle Stimulating Hormone Market Size Overview by Type (2016-2027) 1.3.2 Global Recombinant Follicle Stimulating Hormone Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Recombinant Follicle Stimulating Hormone Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Recombinant Follicle Stimulating Hormone Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Recombinant Follicle Stimulating Hormone Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Recombinant Follicle Stimulating Hormone Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Recombinant Follicle Stimulating Hormone Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Recombinant Follicle Stimulating Hormone Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Recombinant Follicle Stimulating Hormone Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Recombinant Follicle Stimulating Hormone Sales Breakdown by Type (2016-2021) 1.4.2 Europe Recombinant Follicle Stimulating Hormone Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Recombinant Follicle Stimulating Hormone Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Breakdown by Type (2016-2021) 2 Global Recombinant Follicle Stimulating Hormone Market Competition by Company 2.1 Global Top Players by Recombinant Follicle Stimulating Hormone Sales (2016-2021) 2.2 Global Top Players by Recombinant Follicle Stimulating Hormone Revenue (2016-2021) 2.3 Global Top Players Recombinant Follicle Stimulating Hormone Price (2016-2021) 2.4 Global Top Manufacturers Recombinant Follicle Stimulating Hormone Manufacturing Base Distribution, Sales Area, Product Type 2.5 Recombinant Follicle Stimulating Hormone Market Competitive Situation and Trends 2.5.1 Recombinant Follicle Stimulating Hormone Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Recombinant Follicle Stimulating Hormone Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Follicle Stimulating Hormone as of 2020) 2.7 Date of Key Manufacturers Enter into Recombinant Follicle Stimulating Hormone Market 2.8 Key Manufacturers Recombinant Follicle Stimulating Hormone Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Recombinant Follicle Stimulating Hormone Status and Outlook by Region 3.1 Global Recombinant Follicle Stimulating Hormone Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Recombinant Follicle Stimulating Hormone Historic Market Size by Region 3.2.1 Global Recombinant Follicle Stimulating Hormone Sales in Volume by Region (2016-2021) 3.2.2 Global Recombinant Follicle Stimulating Hormone Sales in Value by Region (2016-2021) 3.2.3 Global Recombinant Follicle Stimulating Hormone Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Recombinant Follicle Stimulating Hormone Forecasted Market Size by Region 3.3.1 Global Recombinant Follicle Stimulating Hormone Sales in Volume by Region (2022-2027) 3.3.2 Global Recombinant Follicle Stimulating Hormone Sales in Value by Region (2022-2027) 3.3.3 Global Recombinant Follicle Stimulating Hormone Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Recombinant Follicle Stimulating Hormone by Application 4.1 Recombinant Follicle Stimulating Hormone Market Segment by Application 4.1.1 Infertility Treatment 4.1.2 Assisted Reproductive Technology 4.2 Global Recombinant Follicle Stimulating Hormone Market Size by Application 4.2.1 Global Recombinant Follicle Stimulating Hormone Market Size Overview by Application (2016-2027) 4.2.2 Global Recombinant Follicle Stimulating Hormone Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Recombinant Follicle Stimulating Hormone Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Recombinant Follicle Stimulating Hormone Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Recombinant Follicle Stimulating Hormone Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Recombinant Follicle Stimulating Hormone Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Recombinant Follicle Stimulating Hormone Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Recombinant Follicle Stimulating Hormone Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Recombinant Follicle Stimulating Hormone Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Recombinant Follicle Stimulating Hormone Sales Breakdown by Application (2016-2021) 4.3.2 Europe Recombinant Follicle Stimulating Hormone Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Recombinant Follicle Stimulating Hormone Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Breakdown by Application (2016-2021) 5 North America Recombinant Follicle Stimulating Hormone by Country 5.1 North America Recombinant Follicle Stimulating Hormone Historic Market Size by Country 5.1.1 North America Recombinant Follicle Stimulating Hormone Sales in Volume by Country (2016-2021) 5.1.2 North America Recombinant Follicle Stimulating Hormone Sales in Value by Country (2016-2021) 5.2 North America Recombinant Follicle Stimulating Hormone Forecasted Market Size by Country 5.2.1 North America Recombinant Follicle Stimulating Hormone Sales in Volume by Country (2022-2027) 5.2.2 North America Recombinant Follicle Stimulating Hormone Sales in Value by Country (2022-2027) 6 Europe Recombinant Follicle Stimulating Hormone by Country 6.1 Europe Recombinant Follicle Stimulating Hormone Historic Market Size by Country 6.1.1 Europe Recombinant Follicle Stimulating Hormone Sales in Volume by Country (2016-2021) 6.1.2 Europe Recombinant Follicle Stimulating Hormone Sales in Value by Country (2016-2021) 6.2 Europe Recombinant Follicle Stimulating Hormone Forecasted Market Size by Country 6.2.1 Europe Recombinant Follicle Stimulating Hormone Sales in Volume by Country (2022-2027) 6.2.2 Europe Recombinant Follicle Stimulating Hormone Sales in Value by Country (2022-2027) 7 Asia-Pacific Recombinant Follicle Stimulating Hormone by Region 7.1 Asia-Pacific Recombinant Follicle Stimulating Hormone Historic Market Size by Region 7.1.1 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Recombinant Follicle Stimulating Hormone Forecasted Market Size by Region 7.2.1 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales in Value by Region (2022-2027) 8 Latin America Recombinant Follicle Stimulating Hormone by Country 8.1 Latin America Recombinant Follicle Stimulating Hormone Historic Market Size by Country 8.1.1 Latin America Recombinant Follicle Stimulating Hormone Sales in Volume by Country (2016-2021) 8.1.2 Latin America Recombinant Follicle Stimulating Hormone Sales in Value by Country (2016-2021) 8.2 Latin America Recombinant Follicle Stimulating Hormone Forecasted Market Size by Country 8.2.1 Latin America Recombinant Follicle Stimulating Hormone Sales in Volume by Country (2022-2027) 8.2.2 Latin America Recombinant Follicle Stimulating Hormone Sales in Value by Country (2022-2027) 9 Middle East and Africa Recombinant Follicle Stimulating Hormone by Country 9.1 Middle East and Africa Recombinant Follicle Stimulating Hormone Historic Market Size by Country 9.1.1 Middle East and Africa Recombinant Follicle Stimulating Hormone Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Recombinant Follicle Stimulating Hormone Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Recombinant Follicle Stimulating Hormone Forecasted Market Size by Country 9.2.1 Middle East and Africa Recombinant Follicle Stimulating Hormone Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Recombinant Follicle Stimulating Hormone Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Recombinant Follicle Stimulating Hormone Business 10.1 Merck Serono 10.1.1 Merck Serono Corporation Information 10.1.2 Merck Serono Introduction and Business Overview 10.1.3 Merck Serono Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Merck Serono Recombinant Follicle Stimulating Hormone Products Offered 10.1.5 Merck Serono Recent Development 10.2 MSD 10.2.1 MSD Corporation Information 10.2.2 MSD Introduction and Business Overview 10.2.3 MSD Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Merck Serono Recombinant Follicle Stimulating Hormone Products Offered 10.2.5 MSD Recent Development 10.3 Techwell 10.3.1 Techwell Corporation Information 10.3.2 Techwell Introduction and Business Overview 10.3.3 Techwell Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Techwell Recombinant Follicle Stimulating Hormone Products Offered 10.3.5 Techwell Recent Development 10.4 GenSci 10.4.1 GenSci Corporation Information 10.4.2 GenSci Introduction and Business Overview 10.4.3 GenSci Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021) 10.4.4 GenSci Recombinant Follicle Stimulating Hormone Products Offered 10.4.5 GenSci Recent Development 10.5 Gedeon Richter 10.5.1 Gedeon Richter Corporation Information 10.5.2 Gedeon Richter Introduction and Business Overview 10.5.3 Gedeon Richter Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Gedeon Richter Recombinant Follicle Stimulating Hormone Products Offered 10.5.5 Gedeon Richter Recent Development 10.6 Teva 10.6.1 Teva Corporation Information 10.6.2 Teva Introduction and Business Overview 10.6.3 Teva Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021) 10.6.4 Teva Recombinant Follicle Stimulating Hormone Products Offered 10.6.5 Teva Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Recombinant Follicle Stimulating Hormone Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Recombinant Follicle Stimulating Hormone Industrial Chain Analysis 11.4 Recombinant Follicle Stimulating Hormone Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Recombinant Follicle Stimulating Hormone Distributors 12.3 Recombinant Follicle Stimulating Hormone Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of 75IU Table 2. Major Company of 150IU Table 3. Major Company of Others Table 4. Global Recombinant Follicle Stimulating Hormone Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 5. Global Recombinant Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses) Table 6. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type (2016-2021) Table 7. Global Recombinant Follicle Stimulating Hormone Sales by Type (2016-2021) & (US& Million) Table 8. Global Recombinant Follicle Stimulating Hormone Market Share in Value by Type (2016-2021) Table 9. Global Recombinant Follicle Stimulating Hormone Price by Type (2016-2021) & (USD/Dose) Table 10. Global Recombinant Follicle Stimulating Hormone Sales by Type (2022-2027) & (K Doses) Table 11. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type (2022-2027) Table 12. Global Recombinant Follicle Stimulating Hormone Sales by Type (2022-2027) & (US$ Million) Table 13. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type (2022-2027) Table 14. Global Recombinant Follicle Stimulating Hormone Price by Type (2022-2027) & (USD/Dose) Table 15. North America Recombinant Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses) Table 16. North America Recombinant Follicle Stimulating Hormone Sales by Type (2016-2021) & (US$ Million) Table 17. Europe Recombinant Follicle Stimulating Hormone Sales (K Doses) by Type (2016-2021) Table 18. Europe Recombinant Follicle Stimulating Hormone Sales by Type (2016-2021) & (US$ Million) Table 19. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales (K Doses) by Type (2016-2021) Table 20. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Type (2016-2021) & (US$ Million) Table 21. Latin America Recombinant Follicle Stimulating Hormone Sales (K Doses) by Type (2016-2021) Table 22. Latin America Recombinant Follicle Stimulating Hormone Sales by Type (2016-2021) & (US$ Million) Table 23. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales (K Doses) by Type (2016-2021) Table 24. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Type (2016-2021) & (US$ Million) Table 25. Global Recombinant Follicle Stimulating Hormone Sales by Company (2016-2021) & (K Doses) Table 26. Global Recombinant Follicle Stimulating Hormone Sales Share by Company (2016-2021) Table 27. Global Recombinant Follicle Stimulating Hormone Revenue by Company (2016-2021) & (US$ Million) Table 28. Global Recombinant Follicle Stimulating Hormone Revenue Share by Company (2016-2021) Table 29. Global Market Recombinant Follicle Stimulating Hormone Price by Company (2016-2021) & (USD/Dose) Table 30. Global Recombinant Follicle Stimulating Hormone Top Manufacturers Manufacturing Base Distribution and Sales Area Table 31. Global Recombinant Follicle Stimulating Hormone Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Follicle Stimulating Hormone as of 2020 Table 33. Date of Key Manufacturers Enter into Recombinant Follicle Stimulating Hormone Market Table 34. Key Manufacturers Recombinant Follicle Stimulating Hormone Product Type Table 35. Mergers & Acquisitions, Expansion Plans Table 36. Global Recombinant Follicle Stimulating Hormone Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 37. Global Recombinant Follicle Stimulating Hormone Sales by Region (2016-2021) & (K Doses) Table 38. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Region (2016-2021) Table 39. Global Recombinant Follicle Stimulating Hormone Sales by Region (2016-2021) & (US$ Million) Table 40. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Region (2016-2021) Table 41. Global Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 42. Global Recombinant Follicle Stimulating Hormone Sales by Region (2022-2027) & (K Doses) Table 43. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Region (2022-2027) Table 44. Global Recombinant Follicle Stimulating Hormone Sales by Region (2022-2027) & (US$ Million) Table 45. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Region (2022-2027) Table 46. Global Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2022-2027) Table 47. Global Recombinant Follicle Stimulating Hormone Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 48. Global Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) & (K Doses) Table 49. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Application (2016-2021) Table 50. Global Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) & (US$ Million) Table 51. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application (2016-2021) Table 52. Global Recombinant Follicle Stimulating Hormone Price by Application (2016-2021) & (USD/Dose) Table 53. Global Recombinant Follicle Stimulating Hormone Sales by Application (2022-2027) & (K Doses) Table 54. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Application (2022-2027) Table 55. Global Recombinant Follicle Stimulating Hormone Sales by Application (2022-2027) & (US$ Million) Table 56. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application (2022-2027) Table 57. Global Recombinant Follicle Stimulating Hormone Price by Application (2022-2027) & (USD/Dose) Table 58. North America Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) (K Doses) Table 59. North America Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) & (US$ Million) Table 60. North America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application in 2020 Table 61. Europe Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) (K Doses) Table 62. Europe Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) & (US$ Million) Table 63. Europe Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application in 2020 Table 64. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) (K Doses) Table 65. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) & (US$ Million) Table 66. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application in 2020 Table 67. Latin America Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) (K Doses) Table 68. Latin America Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) & (US$ Million) Table 69. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application in 2020 Table 70. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) (K Doses) Table 71. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) & (US$ Million) Table 72. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application in 2020 Table 73. North America Recombinant Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses) Table 74. North America Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Country (2016-2021) Table 75. North America Recombinant Follicle Stimulating Hormone Sales by Country (2016-2021) & (US$ Million) Table 76. North America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Country (2016-2021) Table 77. North America Recombinant Follicle Stimulating Hormone Sales by Country (2022-2027) & (K Doses) Table 78. North America Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Country (2022-2027) Table 79. North America Recombinant Follicle Stimulating Hormone Sales by Country (2022-2027) & (US$ Million) Table 80. North America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Country (2022-2027) Table 81. Europe Recombinant Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses) Table 82. Europe Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Country (2016-2021) Table 83. Europe Recombinant Follicle Stimulating Hormone Sales by Country (2016-2021) & (US$ Million) Table 84. Europe Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Country (2016-2021) Table 85. Europe Recombinant Follicle Stimulating Hormone Sales by Country (2022-2027) & (K Doses) Table 86. Europe Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Country (2022-2027) Table 87. Europe Recombinant Follicle Stimulating Hormone Sales by Country (2022-2027) & (US$ Million) Table 88. Europe Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Country (2022-2027) Table 89. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Region (2016-2021) & (K Doses) Table 90. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Region (2016-2021) Table 91. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Region (2016-2021) & (US$ Million) Table 92. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Region (2016-2021) Table 93. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Region (2022-2027) & (K Doses) Table 94. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Region (2022-2027) Table 95. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Region (2022-2027) & (US$ Million) Table 96. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Region (2022-2027) Table 97. Latin America Recombinant Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses) Table 98. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Country (2016-2021) Table 99. Latin America Recombinant Follicle Stimulating Hormone Sales by Country (2016-2021) & (US$ Million) Table 100. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Country (2016-2021) Table 101. Latin America Recombinant Follicle Stimulating Hormone Sales by Country (2022-2027) & (K Doses) Table 102. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Country (2022-2027) Table 103. Latin America Recombinant Follicle Stimulating Hormone Sales by Country (2022-2027) & (US$ Million) Table 104. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Country (2022-2027) Table 105. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses) Table 106. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Country (2016-2021) Table 107. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Country (2016-2021) & (US$ Million) Table 108. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Country (2016-2021) Table 109. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Country (2022-2027) & (K Doses) Table 110. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Country (2022-2027) Table 111. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Country (2022-2027) & (US$ Million) Table 112. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Country (2022-2027) Table 113. Merck Serono Corporation Information Table 114. Merck Serono Introduction and Business Overview Table 115. Merck Serono Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021) Table 116. Merck Serono Recombinant Follicle Stimulating Hormone Product Table 117. Merck Serono Recent Development Table 118. MSD Corporation Information Table 119. MSD Introduction and Business Overview Table 120. MSD Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021) Table 121. MSD Recombinant Follicle Stimulating Hormone Product Table 122. MSD Recent Development Table 123. Techwell Corporation Information Table 124. Techwell Introduction and Business Overview Table 125. Techwell Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021) Table 126. Techwell Recombinant Follicle Stimulating Hormone Product Table 127. Techwell Recent Development Table 128. GenSci Corporation Information Table 129. GenSci Introduction and Business Overview Table 130. GenSci Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021) Table 131. GenSci Recombinant Follicle Stimulating Hormone Product Table 132. GenSci Recent Development Table 133. Gedeon Richter Corporation Information Table 134. Gedeon Richter Introduction and Business Overview Table 135. Gedeon Richter Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021) Table 136. Gedeon Richter Recombinant Follicle Stimulating Hormone Product Table 137. Gedeon Richter Recent Development Table 138. Teva Corporation Information Table 139. Teva Introduction and Business Overview Table 140. Teva Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021) Table 141. Teva Recombinant Follicle Stimulating Hormone Product Table 142. Teva Recent Development Table 143. Key Raw Materials Lists Table 144. Raw Materials Key Suppliers Lists Table 145. Recombinant Follicle Stimulating Hormone Market Trends Table 146. Recombinant Follicle Stimulating Hormone Market Drivers Table 147. Recombinant Follicle Stimulating Hormone Market Challenges Table 148. Recombinant Follicle Stimulating Hormone Market Restraints Table 149. Recombinant Follicle Stimulating Hormone Distributors List Table 150. Recombinant Follicle Stimulating Hormone Downstream Customers Table 151. Research Programs/Design for This Report Table 152. Key Data Information from Secondary Sources Table 153. Key Data Information from Primary Sources List of Figures Figure 1. Recombinant Follicle Stimulating Hormone Product Picture Figure 2. Global Recombinant Follicle Stimulating Hormone Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Recombinant Follicle Stimulating Hormone Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Recombinant Follicle Stimulating Hormone Sales Status and Outlook (2016-2027) & (K Doses) Figure 5. Product Picture of 75IU Figure 6. Global 75IU Sales YoY Growth (2016-2021) & (K Doses) Figure 7. Product Picture of 150IU Figure 8. Global 150IU Sales YoY Growth (2016-2021) & (K Doses) Figure 9. Product Picture of Others Figure 10. Global Others Sales YoY Growth (2016-2021) & (K Doses) Figure 11. Global Recombinant Follicle Stimulating Hormone Sales by Type (2016-2027) & (US$ Million) Figure 12. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type (2016-2021) Figure 13. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type (2016-2021) Figure 14. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type (2022-2027) Figure 15. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type (2022-2027) Figure 16. North America Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2020 Figure 17. North America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type in 2020 Figure 18. Europe Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2020 Figure 19. Europe Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type in 2020 Figure 20. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2020 Figure 21. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type in 2020 Figure 22. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2020 Figure 23. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type in 2020 Figure 24. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2020 Figure 25. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type in 2020 Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Follicle Stimulating Hormone Sales in 2020 Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Follicle Stimulating Hormone Revenue in 2020 Figure 28. Recombinant Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 29. Product Picture of Infertility Treatment Figure 30. Global Infertility Treatment Sales YoY Growth (2016-2027) & (K Doses) Figure 31. Product Picture of Assisted Reproductive Technology Figure 32. Global Assisted Reproductive Technology Sales YoY Growth (2016-2027) & (K Doses) Figure 33. Global Recombinant Follicle Stimulating Hormone Sales by Application (2016-2027) & (US$ Million) Figure 34. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Application (2016-2021) Figure 35. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application (2016-2021) Figure 36. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Application (2022-2027) Figure 37. North America Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Application in 2020 Figure 38. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application in 2020 Figure 39. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application in 2020 Figure 40. Key Raw Materials Price Figure 41. Recombinant Follicle Stimulating Hormone Manufacturing Cost Structure Figure 42. Recombinant Follicle Stimulating Hormone Industrial Chain Analysis Figure 43. Channels of Distribution Figure 44. Distributors Profiles Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation Figure 47. Key Executives Interviewed

Merck Serono MSD Techwell GenSci Gedeon Richter Teva